《Science,6月11日,Type I and III interferons disrupt lung epithelial repair during recovery from viral infection》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-06-14
  • REPORT

    Type I and III interferons disrupt lung epithelial repair during recovery from viral infection

    View ORCID ProfileJack Major1, View ORCID ProfileStefania Crotta1, Miriam Llorian2, View ORCID ProfileTeresa M. McCabe1,*, View ORCID ProfileHans Henrik Gad3, Simon L. Priestnall4,5, View ORCID ProfileRune Hartmann3, View ORCID ProfileAndreas Wack1,†

    See all authors and affiliations

    Science 11 Jun 2020:

    eabc2061

    DOI: 10.1126/science.abc2061

    Abstract

    Excessive cytokine signaling frequently exacerbates lung tissue damage during respiratory viral infection. Type I (IFN-α/β) and III (IFN-λ) interferons are host-produced antiviral cytokines. Prolonged IFN-α/β responses can lead to harmful proinflammatory effects, whereas IFN-λ mainly signals in epithelia, inducing localized antiviral immunity. Here we show that IFN signaling interferes with lung repair during influenza recovery, with IFN-λ driving these effects most potently. IFN-induced p53 directly reduces epithelial proliferation and differentiation, increasing disease severity, and susceptibility to bacterial superinfections. Thus, excessive or prolonged IFN-production aggravates viral infection by impairing lung epithelial regeneration. Therefore, timing and duration are critical parameters of endogenous IFN action and should be considered carefully for IFN therapeutic strategies against viral infections like influenza and coronavirus disease 2019 (COVID-19).

  • 原文来源:https://science.sciencemag.org/content/early/2020/06/10/science.abc2061
相关报告
  • 《CELL,6月19日,Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-20
    • Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells Megan L. Stanifer Carmon Kee Mirko Cortese Theodore Alexandrov Open AccessPublished:June 19, 2020DOI:https://doi.org/10.1016/j.celrep.2020.107863 Summary SARS-CoV-2 is an unprecedented worldwide health problem that requires concerted and global approaches to stop the COVID-19 pandemic. Although SARS-CoV-2 primarily targets lung epithelium cells, there is growing evidence that the intestinal epithelium is also infected. Here, using both colon-derived cell lines and primary non-transformed colon organoids, we engage in the first comprehensive analysis of SARS-CoV-2 lifecycle in human intestinal epithelial cells (hIECs). Our results demonstrate that hIECs fully support SARS-CoV-2 infection, replication and production of infectious de-novo virus particles. We found that viral infection elicited an extremely robust intrinsic immune response where interferon-mediated responses were efficient at controlling SARS-CoV-2 replication and de-novo virus production. Taken together, our data demonstrate that hIECs are a productive site of SARS-CoV-2 replication and suggest that the enteric phase of SARS-CoV-2 may participate in the pathologies observed in COVID-19 patients by contributing in increasing patient viremia and by fueling an exacerbated cytokine response.
  • 《Science,11月24日,Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-12-22
    • Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1 View ORCID ProfileAleksandra Milewska1,2, View ORCID ProfileKatherine Falkowski2, View ORCID ProfileMagdalena Kulczycka3, Ewa Bielecka3, View ORCID ProfileAntonina Naskalska1,... Science Signaling 24 Nov 2020: Vol. 13, Issue 659, eaba9902 DOI: 10.1126/scisignal.aba9902 Abstract Human coronavirus HKU1 (HCoV-HKU1) is associated with respiratory disease and is prevalent worldwide, but an in vitro model for viral replication is lacking. An interaction between the coronaviral spike (S) protein and its receptor is the primary determinant of tissue and host specificity; however, viral entry is a complex process requiring the concerted action of multiple cellular elements. Here, we found that the protease kallikrein 13 (KLK13) was required for the infection of human respiratory epithelial cells and was sufficient to mediate the entry of HCoV-HKU1 into nonpermissive RD cells. We also demonstrated the cleavage of the HCoV-HKU1 S protein by KLK13 in the S1/S2 region, suggesting that KLK13 is the priming enzyme for this virus. Together, these data suggest that protease distribution and specificity determine the tissue and cell specificity of the virus and may also regulate interspecies transmission.